/. Cheson-/-cheson-modifié and .. , Réponse selon RECIST 1.0 / RECIST 1, p.40

L. Jost, ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of Hodgkin's disease, Annals of Oncology, vol.16, issue.suppl_1, pp.53-57, 2007.
DOI : 10.1093/annonc/mdi814

G. Delsol, The 2008 WHO lymphoma classification, Ann Pathol, vol.28, issue.1, 2008.

L. Jost, ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma, Annals of Oncology, vol.16, issue.suppl_1, pp.55-61, 2007.
DOI : 10.1093/annonc/mdi820

R. Fisher, E. Gaynor, S. Dahlberg, M. Oken, T. Grogan et al., Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.328, issue.14, pp.1002-1008, 1993.
DOI : 10.1056/NEJM199304083281404

C. Nouvel, H. Tilly, P. Lederlin, C. Sebban, J. Brière et al., Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study, J Clin Oncol, vol.18, issue.16, pp.3025-3055, 2000.

E. Neste, G. Salles, P. Gaulard, F. Reyes, P. Lederlin et al., CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

B. Coiffier, Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte, J

E. Eisenhauer, M. Bonetti, and R. Gelber, Principles of clinical trials, Textbook of Medical Oncology, 2000.

P. Therasse, S. Arbuck, E. Eisenhauer, J. Wanders, R. Kaplan et al., New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

J. Verweij, New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer, vol.45, issue.2, pp.228-275, 2009.

N. Harris, J. Armitage, W. Carter, R. Hoppe, and G. Canellos, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, J Clin Oncol, vol.17, issue.4, pp.1244-53, 1999.

R. Fisher, A. Hagenbeek, E. Zucca, S. Rosen, S. Stroobants et al., International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma, J Clin Oncol, vol.25, issue.5, pp.579-86, 2007.

S. Assouline, R. Meyer, C. Infante-rivard, J. Connors, A. Belch et al., Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria, Leukemia & Lymphoma, vol.115, issue.3, pp.513-533, 2007.
DOI : 10.1200/JCO.2005.08.955

R. Castellino and S. Marglin, Imaging of Abdominal and Pelvic Lymph Nodes Lymphography or Computed Tomography?, Investigative Radiology, vol.17, issue.5, pp.433-476, 1982.
DOI : 10.1097/00004424-198209000-00001

D. Einstein, A. Singer, W. Chilcote, and R. Desai, Abdominal lymphadenopathy: spectrum of CT findings., RadioGraphics, vol.11, issue.3, pp.457-72, 1991.
DOI : 10.1148/radiographics.11.3.1852937

E. Lewis, M. Bernardino, P. Salvador, F. Cabanillas, P. Barnes et al., Post-Therapy CT-Detected Mass in Lymphoma Patients, Journal of Computer Assisted Tomography, vol.6, issue.4, pp.792-797, 1982.
DOI : 10.1097/00004728-198208000-00025

R. Dorfman, M. Alpern, B. Gross, and M. Sandler, Upper abdominal lymph nodes: criteria for normal size determined with CT., Radiology, vol.180, issue.2, pp.319-341, 1991.
DOI : 10.1148/radiology.180.2.2068292

G. Glazer, B. Gross, L. Quint, I. Francis, F. Bookstein et al., Normal mediastinal lymph nodes: number and size according to
DOI : 10.2214/ajr.144.2.261

URL : http://www.ajronline.org/doi/pdf/10.2214/ajr.144.2.261

K. Kiyono, S. Sone, F. Sakai, Y. Imai, T. Watanabe et al., The number and size of normal mediastinal lymph nodes: a postmortem study, American Journal of Roentgenology, vol.150, issue.4, pp.771-777, 1988.
DOI : 10.2214/ajr.150.4.771

H. Steinkamp, M. Cornehl, N. Hosten, W. Pegios, T. Vogl et al., Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy, The British Journal of Radiology, vol.54, issue.807
DOI : 10.1148/radiology.183.1.1549675

H. Matsuoka, T. Masaki, M. Sugiyama, Y. Atomi, Y. Ohkura et al., Morphological characteristics of lateral pelvic lymph nodes in rectal carcinoma, Langenbeck's Archives of Surgery, vol.13, issue.5, pp.543-550, 2007.
DOI : 10.2214/ajr.150.4.771

J. Konishi, K. Yamazaki, E. Tsukamoto, N. Tamaki, Y. Onodera et al., Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings, Respiration, vol.70, issue.5
DOI : 10.1159/000074207

D. Ilson and G. Schwartz, Measuring tumor response and shape change on CT: esophageal cancer as a paradigm, Ann Oncol, vol.17, issue.6, pp.1018-1041, 2006.

T. Lister, D. Crowther, S. Sutcliffe, E. Glatstein, G. Canellos et al., Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting., Journal of Clinical Oncology, vol.7, issue.11, pp.1630-1636, 1989.
DOI : 10.1200/JCO.1989.7.11.1630

A. Grillo-lópez, B. Cheson, S. Horning, B. Peterson, W. Carter et al., Response criteria for NHL: Importance of ???normal??? lymph node size and correlations with response rates, Annals of Oncology, vol.11, issue.4, pp.399-408, 2000.
DOI : 10.1023/A:1008332713631

O. Selawry, W. Regelson, L. Lasagna, and A. Owens, Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and thio phosphoamide, J Chronic Dis, vol.11, issue.1, pp.7-33, 1960.

G. Jerusalem, Y. Beguin, M. Fassotte, F. Najjar, P. Paulus et al., Whole-body positron emission tomography using 18F-fluorodeoxyglucose for post treatment evaluation in

M. De-wit, K. Bohuslavizki, R. Buchert, D. Bumann, M. Clausen et al., 18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma, Annals of Oncology, vol.12, issue.1
DOI : 10.1023/A:1008357126404

M. Juweid and B. Cheson, Positron-Emission Tomography and Assessment of Cancer Therapy, New England Journal of Medicine, vol.354, issue.5, pp.496-507, 2006.
DOI : 10.1056/NEJMra050276

C. Olweny, Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease, J Clin Oncol, vol.8, issue.9, p.1598, 1990.

L. Ollivier, J. Leclère, P. Thiesse, D. Stefano, D. Vincent et al., Measurement of tumour response to cancer treatment: morphologic imaging role, Bull Cancer, vol.94, issue.2, pp.171-178, 2007.

K. James, E. Eisenhauer, and P. Therasse, Re: Measure Once or Twice Does It Really Matter?, JNCI Journal of the National Cancer Institute, vol.91, issue.6, pp.1780-1781, 1999.
DOI : 10.1093/jnci/91.6.523

URL : https://academic.oup.com/jnci/article-pdf/91/20/1780/7795691/1780.pdf

Y. Menu, Evaluation of tumour response to treatment with targeted therapies: standard or targeted criteria? Bull Cancer, pp.231-240, 2007.

M. Mazumdar, A. Smith, and L. Schwartz, A statistical simulation study finds discordance between WHO criteria and RECIST guideline, Journal of Clinical Epidemiology, vol.57, issue.4, pp.358-65, 2004.
DOI : 10.1016/j.jclinepi.2003.07.015

J. Fuks, J. Aisner, and P. Wiernik, Restaging laparotomy in the management of the

S. Hubbard and R. Young, Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management, J Clin Oncol, vol.6, issue.12, pp.1832-1869, 1988.

B. Coiffier, C. Gisselbrecht, R. Herbrecht, H. Tilly, A. Bosly et al., LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma., Journal of Clinical Oncology, vol.7, issue.8, pp.1018-1044, 1989.
DOI : 10.1200/JCO.1989.7.8.1018

S. Milan and T. Hickish, Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma, J Clin Oncol, vol.11, issue.11, pp.2273-2281, 1993.

D. Gaitini, G. Kolodny, and D. Front, Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake, J Clin Oncol, vol.13, issue.4, pp.942-948, 1995.

J. Armitage, Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma, J Clin Oncol, vol.14, issue.9, pp.2473-2482, 1996.

D. Hernandez-maraver, F. Hernandez-navarro, N. Gomes-leon, J. Coya, B. Rodriguez-vigil et al., Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma, British Journal of Haematology, vol.238, issue.3, pp.293-302, 2006.
DOI : 10.1007/s00277-001-0390-y

J. Zijlstra, G. Van-der-werf, O. Hoekstra, L. Hooft, I. Riphagen et al., 18F- fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: A systematic review, Haematologica, vol.91, issue.4, pp.522-531, 2006.

P. Vandenberghe, D. Wolf-peeters, and C. , FDG PET monitoring of tumour response to chemotherapy: does (18)FDG uptake correlate with the viable tumour cell fraction?

E. Lepage, F. Reyes, and M. Meignan, [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome, Blood, vol.106, issue.4, pp.1376-81, 2005.